The Utility of the Platelet–Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Utility of the Platelet–Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction
Authors
Keywords
-
Journal
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
Volume 21, Issue 3, Pages 223-228
Publisher
SAGE Publications
Online
2014-01-16
DOI
10.1177/1076029613519851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention
- (2013) Nihat Sen et al. ATHEROSCLEROSIS
- Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings
- (2013) Uğur Arslan et al. CORONARY ARTERY DISEASE
- Relation of Neutrophil/Lymphocyte Ratio to Coronary Flow to In-Hospital Major Adverse Cardiac Events in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention
- (2012) Mahmut Akpek et al. AMERICAN JOURNAL OF CARDIOLOGY
- Incidence and Outcomes of No-Reflow Phenomenon During Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction
- (2012) Robert W. Harrison et al. AMERICAN JOURNAL OF CARDIOLOGY
- Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
- (2012) Yaron Arbel et al. ATHEROSCLEROSIS
- Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study
- (2012) Bríain ó Hartaigh et al. ATHEROSCLEROSIS
- Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease
- (2012) Hasan Kaya et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention
- (2012) Hai-Yan Xu et al. CORONARY ARTERY DISEASE
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
- (2012) Supachai Raungkaewmanee et al. Journal of Gynecologic Oncology
- Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction
- (2012) Basem Azab et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Usefulness of the SYNTAX Score to Predict “No Reflow” in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
- (2011) Michael Magro et al. AMERICAN JOURNAL OF CARDIOLOGY
- 5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
- (2010) Gjin Ndrepepa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocardial No-Reflow in Humans
- (2009) Giampaolo Niccoli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The impact of admission C-reactive protein levels on the development of no-reflow phenomenon after primary PCI in patients with acute myocardial infarction: The role of inflammation
- (2008) Turgay Celik et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio
- (2008) Richard A. Smith et al. JOURNAL OF GASTROINTESTINAL SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started